{"count": 10, "results": [{"_id": "35675846", "pmid": 35675846, "title": "Investigation of mechanisms underlying the inhibitory effects of metformin against proliferation and growth of neuroblastoma SH-SY5Y cells.", "journal": "Toxicol In Vitro", "authors": ["Binlateh T", "Reudhabibadh R", "Prommeenate P", "Hutamekalin P"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.tiv.2022.105410", "meta_date_publication": "2022 Sep", "meta_volume": "83", "meta_issue": "", "meta_pages": "105410", "score": 50258.855, "text_hl": "Investigation of mechanisms underlying the inhibitory effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against proliferation and growth of @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ @CELLLINE_CVCL:0019 @@@SH-SY5Y@@@ cells.", "citations": {"NLM": "Binlateh T, Reudhabibadh R, Prommeenate P, Hutamekalin P. Investigation of mechanisms underlying the inhibitory effects of metformin against proliferation and growth of neuroblastoma SH-SY5Y cells. Toxicol In Vitro. 2022 Sep;83():105410. PMID: 35675846", "BibTeX": "@article{35675846, title={Investigation of mechanisms underlying the inhibitory effects of metformin against proliferation and growth of neuroblastoma SH-SY5Y cells.}, author={Binlateh T and Reudhabibadh R and Prommeenate P and Hutamekalin P}, journal={Toxicol In Vitro}, volume={83}, pages={105410}}"}}, {"_id": "37623854", "pmid": 37623854, "pmcid": "PMC10456943", "title": "Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts", "journal": "Metabolites", "authors": ["Catalano L", "Aminzadeh-Gohari S", "Weber DD", "Poupardin R", "Stefan VE", "Smiles WJ", "Tevini J", "Feichtinger RG", "Derdak S", "Bilban M", "Bareswill S", "Heimesaat MM", "Kofler B"], "date": "2023-08-03T00:00:00Z", "doi": "10.3390/metabo13080910", "meta_date_publication": "2023 Aug 3", "meta_volume": "13", "meta_issue": "8", "meta_pages": "", "score": 50253.777, "text_hl": "Triple Therapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, Ketogenic Diet, and Metronomic @CHEMICAL_Cyclophosphamide @CHEMICAL_MESH:D003520 @@@Cyclophosphamide@@@ Reduced @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Tumor@@@ Growth in @GENE_MYCN @GENE_4613 @@@MYCN@@@-Amplified @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@Neuroblastoma@@@ Xenografts", "citations": {"NLM": "Catalano L, Aminzadeh-Gohari S, Weber DD, Poupardin R, Stefan VE, Smiles WJ, Tevini J, Feichtinger RG, Derdak S, Bilban M, Bareswill S, Heimesaat MM, Kofler B. Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts Metabolites. 2023 Aug 3;13(8):. PMID: 37623854", "BibTeX": "@article{37623854, title={Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts}, author={Catalano L and Aminzadeh-Gohari S and Weber DD and Poupardin R and Stefan VE and Smiles WJ and Tevini J and Feichtinger RG and Derdak S and Bilban M and Bareswill S and Heimesaat MM and Kofler B}, journal={Metabolites}, volume={13}, number={8}}"}}, {"_id": "25120382", "pmid": 25120382, "pmcid": "PMC4128937", "title": "Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA", "journal": "Cancer Cell Int", "authors": ["Costa D", "Gigoni A", "Würth R", "Cancedda R", "Florio T", "Pagano A"], "date": "2014-07-02T00:00:00Z", "doi": "10.1186/1475-2867-14-59", "meta_date_publication": "2014", "meta_volume": "14", "meta_issue": "", "meta_pages": "59", "score": 50090.79, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ cell growth", "citations": {"NLM": "Costa D, Gigoni A, Würth R, Cancedda R, Florio T, Pagano A. Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA Cancer Cell Int. 2014;14():59. PMID: 25120382", "BibTeX": "@article{25120382, title={Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA}, author={Costa D and Gigoni A and Würth R and Cancedda R and Florio T and Pagano A}, journal={Cancer Cell Int}, volume={14}, pages={59}}"}}, {"_id": "27799938", "pmid": 27799938, "pmcid": "PMC5069360", "title": "PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs", "journal": "PPAR Res", "authors": ["Vella S", "Conaldi PG", "Florio T", "Pagano A"], "date": "2016-01-01T00:00:00Z", "doi": "10.1155/2016/3038164", "meta_date_publication": "2016", "meta_volume": "2016", "meta_issue": "", "meta_pages": "3038164", "score": 50079.195, "text_hl": "...2.2. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@Neuroblastoma@@@", "citations": {"NLM": "Vella S, Conaldi PG, Florio T, Pagano A. PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs PPAR Res. 2016;2016():3038164. PMID: 27799938", "BibTeX": "@article{27799938, title={PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs}, author={Vella S and Conaldi PG and Florio T and Pagano A}, journal={PPAR Res}, volume={2016}, pages={3038164}}"}}, {"_id": "30911317", "pmid": 30911317, "pmcid": "PMC6399528", "title": "Metformin Promotes Neuronal Differentiation via Crosstalk between Cdk5 and Sox6 in Neuroblastoma Cells", "journal": "Evid Based Complement Alternat Med", "authors": ["Binlateh T", "Tanasawet S", "Rattanaporn O", "Sukketsiri W", "Hutamekalin P"], "date": "2019-02-19T00:00:00Z", "doi": "10.1155/2019/1765182", "meta_date_publication": "2019", "meta_volume": "2019", "meta_issue": "", "meta_pages": "1765182", "score": 50072.47, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has recently emerged as a key player in promotion of @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ differentiation and neurite outgrowth. ", "citations": {"NLM": "Binlateh T, Tanasawet S, Rattanaporn O, Sukketsiri W, Hutamekalin P. Metformin Promotes Neuronal Differentiation via Crosstalk between Cdk5 and Sox6 in Neuroblastoma Cells Evid Based Complement Alternat Med. 2019;2019():1765182. PMID: 30911317", "BibTeX": "@article{30911317, title={Metformin Promotes Neuronal Differentiation via Crosstalk between Cdk5 and Sox6 in Neuroblastoma Cells}, author={Binlateh T and Tanasawet S and Rattanaporn O and Sukketsiri W and Hutamekalin P}, journal={Evid Based Complement Alternat Med}, volume={2019}, pages={1765182}}"}}, {"_id": "25365944", "pmid": 25365944, "pmcid": "PMC4294363", "title": "Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma", "journal": "Oncotarget", "authors": ["Kumar A", "Al-Sammarraie N", "DiPette DJ", "Singh US"], "date": "2014-11-30T00:00:00Z", "doi": "10.18632/oncotarget.2606", "meta_date_publication": "2014 Nov 30", "meta_volume": "5", "meta_issue": "22", "meta_pages": "11709-22", "score": 50067.008, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ growth in vivo", "citations": {"NLM": "Kumar A, Al-Sammarraie N, DiPette DJ, Singh US. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma Oncotarget. 2014 Nov 30;5(22):11709-22. PMID: 25365944", "BibTeX": "@article{25365944, title={Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma}, author={Kumar A and Al-Sammarraie N and DiPette DJ and Singh US}, journal={Oncotarget}, volume={5}, number={22}, pages={11709-22}}"}}, {"_id": "27924056", "pmid": 27924056, "pmcid": "PMC5173176", "title": "Correction: Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma", "journal": "Oncotarget", "authors": ["Kumar A", "Al-Sammarraie N", "DiPette DJ", "Singh US"], "date": "2016-07-05T00:00:00Z", "doi": "10.18632/oncotarget.10404", "meta_date_publication": "2016 Jul 5", "meta_volume": "7", "meta_issue": "27", "meta_pages": "42843", "score": 50060.656, "text_hl": "Rho GTPase inhibitors attenuate @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ effects on the survival of @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ cells", "citations": {"NLM": "Kumar A, Al-Sammarraie N, DiPette DJ, Singh US. Correction: Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma Oncotarget. 2016 Jul 5;7(27):42843. PMID: 27924056", "BibTeX": "@article{27924056, title={Correction: Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma}, author={Kumar A and Al-Sammarraie N and DiPette DJ and Singh US}, journal={Oncotarget}, volume={7}, number={27}, pages={42843}}"}}, {"_id": "24190252", "pmid": 24190252, "pmcid": "PMC3868499", "title": "Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin", "journal": "Int J Mol Med", "authors": ["Wang SS", "Hsiao R", "Limpar MM", "Lomahan S", "Tran TA", "Maloney NJ", "Ikegaki N", "Tang XX"], "date": "2014-01-01T00:00:00Z", "doi": "10.3892/ijmm.2013.1545", "meta_date_publication": "2014 Jan", "meta_volume": "33", "meta_issue": "1", "meta_pages": "35-42", "score": 50057.938, "text_hl": "We investigated the anticancer mechanisms of action of @CHEMICAL_3_Iodobenzylguanidine @CHEMICAL_MESH:D019797 @@@MIBG@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@NB@@@. ", "citations": {"NLM": "Wang SS, Hsiao R, Limpar MM, Lomahan S, Tran TA, Maloney NJ, Ikegaki N, Tang XX. Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin Int J Mol Med. 2014 Jan;33(1):35-42. PMID: 24190252", "BibTeX": "@article{24190252, title={Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin}, author={Wang SS and Hsiao R and Limpar MM and Lomahan S and Tran TA and Maloney NJ and Ikegaki N and Tang XX}, journal={Int J Mol Med}, volume={33}, number={1}, pages={35-42}}"}}, {"_id": "26635517", "pmid": 26635517, "pmcid": "PMC4655242", "title": "Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells", "journal": "Front Neurosci", "authors": ["Mouhieddine TH", "Nokkari A", "Itani MM", "Chamaa F", "Bahmad H", "Monzer A", "El-Merahbi R", "Daoud G", "Eid A", "Kobeissy FH", "Abou-Kheir W"], "date": "2015-11-23T00:00:00Z", "doi": "10.3389/fnins.2015.00442", "meta_date_publication": "2015", "meta_volume": "9", "meta_issue": "", "meta_pages": "442", "score": 50051.98, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an adenosine monophosphate-activated protein kinase (@GENE_PRKAA2 @GENE_5563 @@@AMPK@@@) activator, was effective in suppressing and killing @DISEASE_Glioma @DISEASE_MESH:D005910 @@@glioma@@@ and @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ cells (Isakovic et al.,; Shackelford and Shaw,; Kumar et al.,; Liu et al.,). ", "citations": {"NLM": "Mouhieddine TH, Nokkari A, Itani MM, Chamaa F, Bahmad H, Monzer A, El-Merahbi R, Daoud G, Eid A, Kobeissy FH, Abou-Kheir W. Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells Front Neurosci. 2015;9():442. PMID: 26635517", "BibTeX": "@article{26635517, title={Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells}, author={Mouhieddine TH and Nokkari A and Itani MM and Chamaa F and Bahmad H and Monzer A and El-Merahbi R and Daoud G and Eid A and Kobeissy FH and Abou-Kheir W}, journal={Front Neurosci}, volume={9}, pages={442}}"}}, {"_id": "25504439", "pmid": 25504439, "pmcid": "PMC4359268", "title": "Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer", "journal": "Oncotarget", "authors": ["Vujic I", "Sanlorenzo M", "Posch C", "Esteve-Puig R", "Yen AJ", "Kwong A", "Tsumura A", "Murphy R", "Rappersberger K", "Ortiz-Urda S"], "date": "2015-01-20T00:00:00Z", "doi": "10.18632/oncotarget.2824", "meta_date_publication": "2015 Jan 20", "meta_volume": "6", "meta_issue": "2", "meta_pages": "969-78", "score": 50044.168, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_trametinib @CHEMICAL_MESH:C560077 @@@trametinib@@@ effects on @GENE_NRAS @GENE_4893 @@@NRAS@@@ mutant @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung cancer@@@ and @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ cells", "citations": {"NLM": "Vujic I, Sanlorenzo M, Posch C, Esteve-Puig R, Yen AJ, Kwong A, Tsumura A, Murphy R, Rappersberger K, Ortiz-Urda S. Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer Oncotarget. 2015 Jan 20;6(2):969-78. PMID: 25504439", "BibTeX": "@article{25504439, title={Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer}, author={Vujic I and Sanlorenzo M and Posch C and Esteve-Puig R and Yen AJ and Kwong A and Tsumura A and Murphy R and Rappersberger K and Ortiz-Urda S}, journal={Oncotarget}, volume={6}, number={2}, pages={969-78}}"}}]}